Blu – Pagina 84 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Maggio 6, 2024 dario.olivero

Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial

Benhalima K, Beunen K, Van Wilder N, et al.
Lancet Diabetes Endocrinol. Pub. Online 29 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Cardiorenal outcomes and mortality after sodium-glucose cotransporter-2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history

Kim JH, Lyu YS, Kim B, et al.
Diabetes Obes Metab. Pub. Online 21 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Safety of the Pcsk9 inhibitor alirocumab: Insights from 47,296 patient-years of observation

Goodman SG, Steg PG, Szarek M, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. Online 24 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Wang J, Li X, Li Y, Lei C
BMC Endocr Disord. Pub. Online 24 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes

Ng SM, Wright NP, Yardley D, et al.
BMC Med. Pub. Online 24 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants

Almeida OP, Fong Z, Hill Almeida LM, et al.
Diabetes Obes Metab. Pub. Online 23 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Early-onset hypertension and sex-specific residual risk for cardiovascular disease in type 2 diabetes

Ji H, Ebinger JE, Kwan AC, et al.
Diabetes Care. Pub. Online 24 Apr 2024.

Leggi

Maggio 2, 2024 dario.olivero

Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications

Dixit AA, Bateman BT, Hawn MT, et al.
JAMA. Pub. Online 22 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Effect of 5:2 regimens: energy-restricted diet or low-volume high-intensity interval training combined with resistance exercise on glycemic control and cardiometabolic health in adults with overweight/obesity and type 2 diabetes—a three-arm randomized controlled trial

Li M, Li J, Xu Y, et al.
Diabetes Care. Pub. Online 18 Apr 2024.

Leggi

Aprile 24, 2024 dario.olivero

Could glp-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions?

Rubin R
JAMA. Pub. Online 19 Apr 2024.

Leggi